AcelRx Pharmaceuticals (ACRX) Reports In-Line Q2 Loss of 22c/Share

August 12, 2013 4:07 PM

AcelRx Pharmaceuticals (NASDAQ: ACRX) reported Q2 EPS of ($0.22) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found